Kenvue Inc. (NYSEKVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025.

These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.

Activist investor Starboard Value LP has reportedly acquired a 7.7% stake worth approximately $500 million in Qorvo Inc. on Thursday, targeting the struggling semiconductor manufacturer for potential operational changes.

Kenvue Inc. (NYSEKVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue’s common stock. This quarterly dividend is payable on February 26, 2025, to shareholders of record as of the close of business on February 12, 2025.

The following 10 one decision stocks have increased their dividends for over 25 years, making them Dividend Aristocrats.

Investing by equal parts in these three dividend stocks produces an average yield of 3%.

Conservative retirement investing is all about creating passive income with quality securities, held for the long-run.

With a solid technical rating of 8 out of 10, KENVUE INC (NYSEKVUE) is showing strong indications of a possible breakout.

These three dividend-paying companies have all raised their payouts every year for at least 40 consecutive years.

Kenvue Inc. (NYSEKVUE) (“Kenvue”) today announced the Company’s participation in the Morgan Stanley Global Consumer & Retail Conference in New York City. Thibaut Mongon, Chief Executive Officer and Paul Ruh, Chief Financial Officer will participate in a fireside chat on Wednesday, December 4, 2024, at 11:45 a.m. Eastern Time. A live webcast of the fireside chat will be available on investors.kenvue.com and a replay will be available on the website following the event.

KVUE earnings call for the period ending September 30, 2024.

FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued.

Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in Skin Health and Beauty.

Kenvue Inc. (NYSEKVUE) (“Kenvue”), today announced financial results for the fiscal third quarter ended September 29, 2024.

Kenvue Inc. (NYSEKVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establishing multi-year partnerships with Dr. Dhaval Bhanusali, renowned skincare innovator, and Dr. Muneeb Shah, the most followed dermatologist worldwide2.

Can tinkering around the edges actually make this stock more attractive?

While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong portfolio.